About: poractant alfa

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: poractant alfa Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

pharmaceutical drug

Attributes	Values
rdf:type	Item
owl:sameAs	poractant alfa
description	composto chimico (it) composé chimique (fr) תרכובת (he) chemische Verbindung (de) pharmaceutical drug (en) քիմիական միացություն (hy) chemická sloučenina (cs) chemische verbinding (nl) kemia kombinaĵo (eo) związek chemiczny (pl) component quimic (oc) compost químic (ca) composto químico (gl) composto químico (pt) composto químico (pt-br) compuesto quimico (an) compuestu químicu (ast) compus chimic (ro) kemiallinen yhdiste (fi) kjemisk forbindelse (nb) kjemisk sambinding (nn) konposatu kimiko (eu) مركب كيميائي (ar) کیٖمیٲیی مُرَکَب (ks) রাসায়নিক যৌগ (bn) compuesto químico (es)
rdfs:label	poractant alfa (en) poractant alfa (fr) poraktant alfa (nn) poraktant alfa (sl)
skos:prefLabel	poractant alfa (en) poractant alfa (fr) poraktant alfa (nn) poraktant alfa (sl)
name	poractant alfa (en) poractant alfa (fr) poraktant alfa (nn) poraktant alfa (sl)
subject has role	wds:Q15708403-41A01D03-AAA3-4546-82D2-FA814FFDD864
Freebase ID	wds:Q15708403-B346D5CE-27FB-4636-9977-7B9895BFC6A8
subject has role	pulmonary surfactant
Freebase ID	/m/0hqvt4g
has characteristic	wds:Q15708403-8FC5004F-A4DB-4754-B5C0-87237A815696
instance of	wds:Q15708403-A558E4EA-080F-45C0-A778-3E9E25E2521C
has characteristic	biopharmaceutical
instance of	type of chemical entity
subclass of	wds:Q15708403-BC83DCA4-EE37-491B-ACBA-8650C3816033
subclass of	chemical substance
has use	wds:Q15708403-30960D6B-A850-4A36-A81B-9A5D50F99347
has use	medication
NDF-RT ID	wds:Q15708403-0D212DD5-7386-4631-B5FC-61B38BC6D298
CAS Registry Number	wds:Q15708403-E94286A2-C5D7-432A-A460-687C6E3F9944
RxNorm ID	wds:Q15708403-62F2FE41-942B-4ABF-A00D-3D71CED5C715
UNII	wds:Q15708403-6A539A9C-283E-4DF8-B8EB-4590DF851215
DrugBank ID	wds:Q15708403-7780B8BC-3455-4083-9FB2-4461674C8578
NDF-RT ID	http://purl.bioontology.org/ontology/NDFRT/N0000148650
NDF-RT ID	N0000148650
CAS Registry Number	129069-19-8
RxNorm ID	236381
UNII	KE3U2023NP
DrugBank ID	09113
ChEMBL ID	wds:Q15708403-F36F3E4D-C17D-4EAE-8317-C3C7E991BAC5
ChEMBL ID	http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL1201622
ChEMBL ID	CHEMBL1201622
skos:altLabel	Curosurf (en)
NCI Thesaurus ID	wds:Q15708403-36666C1D-9EDB-470C-A971-4760A5A6B74B
MeSH descriptor ID	wds:Q15708403-59E9B657-A4AA-405C-9F14-B2CA72E58A40
Microsoft Academic ID	wds:Q15708403-6D0183FC-C7B8-47A1-BF33-0C4BD5833332
MeSH descriptor ID	http://id.nlm.nih.gov/mesh/C068291
Microsoft Academic ID	https://makg.org/entity/2780566003
NCI Thesaurus ID	C81353
MeSH descriptor ID	C068291
Microsoft Academic ID	2780566003
WikiProjectMed ID	wds:Q15708403-4500A505-7067-4922-BE29-1C7B9291DCAC
WikiProjectMed ID	Poractant alfa
active ingredient in	wds:Q15708403-DA7C61E6-81E4-4F8C-B4B5-04C0EF85B589
active ingredient in	Curosurf
is about of	poractant alfa https://www.wikidata.org/wiki/Special:EntityData/Q15708403 Poractant alfa
is drug or therapy used for treatment of	infant respiratory distress syndrome
is drug or therapy used for treatment of	wds:Q754348-D46A8C5F-2967-4453-94BA-402605062600
is main subject of	Surfactant preparations for preterm infants with respiratory distress syndrome: past, present, and future Health Economics and Outcomes of Surfactant Treatments for Respiratory Distress Syndrome Among Preterm Infants in US Level III/IV Neonatal Intensive Care Units
is main subject of	wds:Q64270080-68B1C624-9B43-466F-B349-19B386287F9D wds:Q64080533-26B05355-36C5-498F-B3ED-A72A06B9A20D
is research intervention of	Poractant Alfa - Curosurf and SARS-COV-19 ARDS (Covid-19) A Study To InvestigateThe Safety, Tolerability And Efficacy Of Nebulised Curosurf® In Preterm Neonates With Respiratory Distress Syndrome (RDS) Evaluation of the Efficacy of Surfaktant in Preterm Infants by Lung Ultrasound Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19 Observational Study on the Prophylactic Use of Curosurf in Neonatal Respiratory Distress Syndrome (RDS) Efficacy of Combining Prophylactic Curosurf With Early Nasal CPAP in Delivery Room: the Curpap Study The Budesonide in Babies (BiB) Trial Late Surfactant After a Recruitment Maneuver in Extremely Low Gestational Age Newborns - LATE-REC-SURF Trial Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia. Comparison in Pulmonary Compliance Between Curosurf and Survanta in Preterm Infants With Respiratory Distress Syndrome Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia.
is research intervention of	wds:Q105789312-FFC64EF6-3F1B-4911-BAA2-D60DD831B507

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software